136 filings
Page 3 of 7
8-K
3b56ikwyiba5da4
20 Jun 12
Idenix Announces Positive Clinical Data for HCV Drug Candidates IDX184 and IDX719
12:00am
8-K
9vi32a
8 Jun 12
Submission of Matters to a Vote of Security Holders
12:00am
8-K
x3or0dayza6xyw6gir
21 May 12
Departure of Directors or Certain Officers
12:00am
8-K
uetn6ukrnzaphxy
2 May 12
Idenix Pharmaceuticals Reports First Quarter 2012 Financial
12:00am
8-K
ucd brb0nfhl059qso
24 Apr 12
Other Events
12:00am
8-K
byyzm56
29 Mar 12
Departure of Directors or Certain Officers
12:00am
8-K
9lnswzyf3 fk4xj936l
6 Mar 12
Board and Appoints Michael Wyzga to Its Board of Directors
12:00am
8-K
4ml83ona5b42g 9lib
23 Feb 12
Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update
12:00am
8-K
2bwe685y534rgc
6 Feb 12
Departure of Directors or Certain Officers
12:00am
8-K
htwiy y0ki
3 Feb 12
Other Events
12:00am
8-K
vepv92bn6999t2do48
9 Jan 12
Idenix Reports Positive Interim Data for HCV Nucleotide Inhibitor, IDX184
12:00am
8-K
f0iybsc8na0vg5ibpae
22 Dec 11
Termination of a Material Definitive Agreement
12:00am
8-K
vx0vt0vvnounlegq
16 Nov 11
Idenix Pharmaceuticals Prices Public Offering of Common Stock
12:00am
8-K
86z195 fmjs5v
2 Nov 11
Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2011 Financial Results and Provides Pipeline Update
12:00am
8-K
wqlq 72qqhzhdx
8 Aug 11
Idenix Pharmaceuticals Reports Second Quarter and Six Month 2011 Financial Results and Provides Pipeline Update
12:00am
8-K
7kogd34
24 Jun 11
Departure of Directors or Certain Officers
12:00am
8-K
0x3t5q0s6r s0c4fh
6 Jun 11
Submission of Matters to a Vote of Security Holders
12:00am
8-K
j6a1kl1f
27 Apr 11
Idenix Pharmaceuticals Reports First Quarter 2011 Financial Results
12:00am
8-K
vtj5zzt8j jr78eln
11 Apr 11
Idenix Pharmaceuticals Prices Public Offering of Common Stock
12:00am
8-K
nhawh72x4t
7 Apr 11
Departure of Directors or Certain Officers
12:00am